Differential effects of contraction and PPAR agonists on the expression of fatty acid transporters in rat skeletal muscle.
about
CD36: implications in cardiovascular diseaseCCAAT/enhancer-binding protein beta deletion reduces adiposity, hepatic steatosis, and diabetes in Lepr(db/db) mice.Skeletal muscle-specific expression of PGC-1α-b, an exercise-responsive isoform, increases exercise capacity and peak oxygen uptake.Enhanced fatty acid oxidation and FATP4 protein expression after endurance exercise training in human skeletal muscle.High fatty acid availability after exercise alters the regulation of muscle lipid metabolismRosiglitazone-Mediated Effects on Skeletal Muscle Gene Expression Correlate with Improvements in Insulin Sensitivity in Individuals with HIV-Insulin ResistancePeroxisome proliferator-activated receptor γ decouples fatty acid uptake from lipid inhibition of insulin signaling in skeletal muscleIs membrane transport of FFA mediated by lipid, protein, or both? Mechanisms and regulation of protein-mediated cellular fatty acid uptake: molecular, biochemical, and physiological evidence.Endogenous peroxisome proliferator-activated receptor-gamma augments fatty acid uptake in oxidative muscle.Greater transport efficiencies of the membrane fatty acid transporters FAT/CD36 and FATP4 compared with FABPpm and FATP1 and differential effects on fatty acid esterification and oxidation in rat skeletal musclePGC-1alpha-induced improvements in skeletal muscle metabolism and insulin sensitivity.Interactions Between Fatty Acid Transport Proteins, Genes That Encode for Them, and Exercise: A Systematic Review.Insulin sensitivity is independent of lipid binding protein trafficking at the plasma membrane in human skeletal muscle: effect of a 3-day, high-fat diet.Rosiglitazone increases fatty acid oxidation and fatty acid translocase (FAT/CD36) but not carnitine palmitoyltransferase I in rat muscle mitochondria.Differential effects of chronic, in vivo, PPAR's stimulation on the myocardial subcellular redistribution of FAT/CD36 and FABPpm.
P2860
Q24678338-0D8BDC5D-7744-46D1-8A27-254B2773E3AFQ33943164-12477F87-DBEE-431C-AE1A-311633328FBCQ34102995-B9431C45-52CF-4E22-AFEA-B1A59EE0920BQ34123675-E67C285C-7358-47AA-BF89-2BE1D3D532D2Q34444424-6AB36154-C352-4907-AB3F-CB12CDE7D499Q34955658-D61870E0-1610-4853-B120-545B691A299BQ35970084-F1195263-0E5A-48BB-A204-A17CE6D8F74FQ36753522-967D9413-AC6F-4E13-8FC1-B1DB9D205D34Q36976374-6118FB9C-CCA4-4D04-8619-8189CA0E4AFDQ37269130-62088120-666C-438E-976C-111E4561A45EQ37485965-FD901EA6-F88F-47EA-A6BC-AF82807C4477Q38660062-CCDA616B-3FE9-4586-8688-E80FA47A663AQ42200100-6A9E7A7F-6F8E-4E43-8A4A-A85DC7345549Q46779978-C4A474D7-A4A7-40A9-9F8B-9CC79776B989Q54733259-7202A2C2-7D42-4D5B-8259-438B7A6A1669
P2860
Differential effects of contraction and PPAR agonists on the expression of fatty acid transporters in rat skeletal muscle.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
Differential effects of contra ...... orters in rat skeletal muscle.
@en
Differential effects of contra ...... orters in rat skeletal muscle.
@nl
type
label
Differential effects of contra ...... orters in rat skeletal muscle.
@en
Differential effects of contra ...... orters in rat skeletal muscle.
@nl
prefLabel
Differential effects of contra ...... orters in rat skeletal muscle.
@en
Differential effects of contra ...... orters in rat skeletal muscle.
@nl
P2093
P2860
P1476
Differential effects of contra ...... orters in rat skeletal muscle.
@en
P2093
Arend Bonen
Carley R Benton
Debby P Y Koonen
Jan F C Glatz
John J Heikkila
Joost J F P Luiken
Jorge Calles-Escandon
Narendra N Tandon
P2860
P304
P356
10.1113/JPHYSIOL.2006.106013
P407
P577
2006-02-16T00:00:00Z